Objective. To describe the characteristics and outcomes of the first 3 years of admissions to a dedicated skilled nursing facility for people with acquired immunodeficiency syndrome (AIDS).
INTRODUCTION
Recent advances in the treatment of human immunodeficiency virus (HIV) infection and its complications have led to improved survival for people with acquired immunodeficiency syndrome (AIDS). 1-3 While for many patients this has resulted in significant improvement in functioning and a return to productive activity, for others the impact of these therapies has been more limited. In some cases, this may be due to medication nonadherence, toxicity, or inaccessibility; in others, it may be due to late-stage HIV disease, antiretroviral drug resistance, or severe dementia or other neurologic disease. In addition, the coexistence of HIV infection and substance abuse, severe mental illness, homelessness, and other overlapping factors all may converge to create a particularly vulnerable population of HIVinfected patients who are unable to benefit fully from the growing therapeutic advances in AIDS care. 4~6
All of these trends have resulted in a need in some areas for the development of long-term care services, including skilled nursing facilities and other institutional settings for the chronic care of people with AIDS. These trends have occurred at the same time as the need for hospice care itself may be decreasing for this population 7-9 (D. Hoos, New York State Department of Health, personal communication, December 1999). Moreover, the need for alternative care settings has also increased with the advent of managed-care systems and the incentive to minimize inpatient hospital utilization costs. While a number of long-term care facilities for people with AIDS have been established in recent years, there has been relatively little published on the characteristics of this new level of care and the actual populations that have been served by these AIDS-designated facilities. [9] [10] [11] [12] [13] In this report, we describe the characteristics and outcomes of the first 3 years of admissions to a dedicated skilled nursing facility for people with AIDS in New Haven, Connecticut.
STUDY SETTING AND METHODS
New Haven, Connecticut, is a small city (population 130,000) located approximately 90 krn northwest of New York City; it has high rates of HIV infection, poverty, and drug use. 14 New Haven was one of the first 12 cities in the US for which AIDS became the leading cause of death for both young adult men and women by the early 1990s. Is In response to a perceived need for long-term care
for people with AIDS, a skilled nursing facility was opened in October 1995.
The facility, called Leeway, is operated as a freestanding, community-based, not-for-profit corporation. Leeway's operating budget is generated through thirdparty reimbursement, of which the principal payer is Medicaid. Descriptive statistics were generated for the entire patient population using the total number of patients as the denominator; for patients with more than one admission during the study period, baseline information was included for only the first admission. Rates of specific outcomes, including transfers, hospitalizations, and deaths, were calculated using total person-days in the facility from all admissions as the denominator. An analysis of discharges was performed for all completed admissions. For the calculation of death rates, deaths were included if they occurred either at the facility or within 2 weeks of discharge or transfer.
Length of stay was calculated for all admissions, including those not yet completed, overall, and by different admission subgroups. A secondary analysis was performed to examine discharge outcomes from the facility to attempt to determine variables on admission that might predict such outcomes as death, discharge to the community, or prolonged length of stay at the nursing home.
For this analysis, we first compared baseline characteristics of patients who died within 6 months of admission to those of all other patients. Then, excluding those who had died within the first 6 months, we compared those who were discharged to the community within the first 6 months to those who resided at the facility for 6 months or more.
Pearson chi-square tests were used to assess the statistical significance of differences in proportions between groups on categorical variables. 
RESULTS
The Leeway facility opened to receive patients on October 1, 1995. By 20 weeks of operation, the facility was filled to capacity, and since that time has remained at 90% of capacity or greater. Over 80% of admissions have been referred from New Haven and the nearby surrounding area, with the remaining 20% from elsewhere in Connecticut.
From October 1, 1995, through December 31, 1998, there were a total of 222 admissions to the facility; these admissions represented 180 unique individuals, of whom 142 had one admission, 34 had two admissions, and 4 had three admissions during this time period. Table I presents selected demographic characteristics and the reasons for admission for the group of 180 patients. Almost onethird were female; the mean age was 41 years; and over half were black or Latino.
Almost three-quarters were admitted directly from a hospital; the most frequent primary reasons for admission were a need for 24-hour medical or nursing supervision (57%), completion of acute medical treatment (23%), and terminal care (13%). Over 90% of all patients were Medicaid recipients ( Table I) . Examination was 23/30, and only slightly more than half the population was fully ambulatory without assistance; 52% had impairment in at least one domain on the ADL Scale (Table II) . The predominant HIV risk behavior in this population was injection drug use (57%), although close to one-quarter had heterosexual contact as a risk factor. Current cocaine or heroin use was reported by 12%, and 12% were on methadone maintenance (Table II) .
Of note was the high prevalence of neurologic and psychiatric illness among nursing home residents (Table III) : 48% had HIV-related neurologic disease, including 32% with dementia, 19% with peripheral neuropathy, 7% with progressive multifocal teukoencephalopathy, and lower percentages with other HIVrelated neurologic conditions. Pre-existing seizure disorders that were not felt to be HIV related were present in 9% of the residents. On admission, 44% of the patients had diagnoses of psychiatric disorders, excluding substance use, dementia, and personality disorders; 29% of the total group had depression or other affective disorders; 11% had anxiety disorders; 8% had schizophrenia or other psychoses; and lower percentages had been diagnosed with other psychiatric disorders.
Patients were admitted to the skilled nursing facility on a median of 11 medications, including more than 80% on antiretroviral therapy and/or on prophylaxis against Pneumocystis carinii pneumonia and over 60% on antifungal and/or antimycobacterial prophylaxis or suppression (Table IV) . Two-thirds of all residents were on analgesic medication, close to two-thirds were on psychiatric medication, and more than half were on anfiemetics, antidiarrheals, or other medications to manage gastrointestinal symptoms. Approximately one-third of the patients were on medications for respiratory symptoms, cytokines, and/or appetite stimulants or anabolic agents. Lower percentages were on cardiac/ circulatory medications, anticonvulsants, and corticosteroids.
Concerning on-site consultations at the facility, 68% of the patients underwent psychiatric consultation, 47% received physical therapy, 35% received podiatry services, 15% were seen by a chiropractor, and 9% received acupuncture and/ or naturopathic treatments. Concerning transfers of residents for acute care and outpatient services or procedures, 23% underwent emergency room evaluation (8.3 visits per 100 person-months), and 39% were hospitalized one or more times during their stays at the facility (13.7 per 100 person-months) ( Table V) . The Of all residents, 25% developed new or recurrent infections during followup after admission to the facility, including (not mutually exclusive) 12% with bacterial pneumonia, 9% with oroesophageal candidiasis, 8% with bacteremia, 7% with herpes zoster, and 4% each with cytomegalovirus disease, cryptosporidiosis, and deep fungal infection (cryptococcosis or aspergillosis).
Of the 222 total admissions to the facility during the study period, there were 202 completed discharges (91%) by the end of the follow-up period on July 1, 1999 (Table VI) . Of these, 44% of the patients died, 39% were discharged to the community, 9% left the facility against medical advice, and 8% were discharged to a hospital. The median overall length of stay at the facility was 59 days; by patient subgroup, the median length of stay was 50 days for those who were discharged home, 66 days for those who died, 114 days for those admitted for long-term nursing care, 37 days for those admitted for completion of acute medical treatment, 28 days for those admitted for respite care, and 15 days for those admitted for terminal care. The overall death rate for patients in the facility was 8 deaths per 100 person-months.
In the examination of predictors of early mortality (<6 months after admission), significant baseline variables included Karnofsky score, Mini-Mental State Examination score, CD4+ count, any impairment in activities of daily living, inability
to ambulate, and psychiatric history (lower prevalence of psychiatric illness in the early mortality group) ( Table VII) .
The analysis of short-term versus long-term stay (those staying less than 6 months compared to those staying 6 months or more), excluding the group that died within the first 6 months, revealed that long-term stay was associated with non-white race, male gender, a baseline neurologic diagnosis, and/or dementia (Table VIII) .
On multivariate analysis of predictors of mortality, stepwise logistic regression indicated that early mortality (<6 months after admission) was predicted by low :~Includes wheelchairbound or bedbound patients.
DISCUSSION
This report describes the initial experience of a dedicated skilled nursing facility for people with AIDS and suggests that this level of care will meet an important service need for long4erm care as the AIDS epidemic matures and AIDS increasingly becomes a chronic disease. Although earlier reports have described the provision of hospice services to people with AIDS 19-22 and the experience of nursing units within hospitals or geriatric nursing homes, 9'1~ this is one of the first studies to examine the experience of a freestanding, AIDS-designated longterm care facility in the era of highly active antiretroviral therapy (HAART). This facility, established in a small urban community with a high rate of AIDS cases, has remained filled to capacity since opening and has become an integral part of the continuum of care in the local AIDS service environment. Although it may be counterintuitive at first consideration, with the increasing effectiveness of antiretroviral therapy and other medical interventions that can prolong life in HIV-infected individuals, it is likely that the need for this level of long-term care will expand. While some patients are able to return to more autonomous levels of functioning as a result of the benefits of the new therapies, for others with late-stage disease or accompanying psychiatric or neurologic disease, their disease course may become one of more prolonged impairment--the conversion of death, in effect, to long-term disability. This may be expected to generate an ongoing need for long-term care options, including skilled nursing facilities such as the one described here. In addition, however, as part of an extending continuum of care, it may become equally important to develop community-based residential alternatives for the growing population of patients that may, with improvements in HIV therapy, be able to be discharged from inpatient facilities.
The population at Leeway has been a heterogeneous one, including patients admitted for short-term convalescence and long-term care, suggesting that such a facility must also be prepared to deal with acute medical issues in addition to the more chronic level of care customary in many nursing homes. In addition, although close to 50% of patients admitted to the facility ultimately died within the observation period, over 30% were discharged home to the community, indicating that there is an important role for rehabilitative services in such institutional settings. In addition, the finding that over 20% of the patient population was admitted for completion of acute medical treatment suggests that this type of facility can play an important and cost-effective role in the management of the complications of HIV disease. From these data alone, at an average daily bed rate of approximately $300 at the skilled nursing facility compared with over $1000 at the facility's major referral hospital, the cost-saving implications for hospitals are evident. Such potential savings will become even more attractive as managed-care plans proliferate, with the important priority of reducing inpatient hospital lengths of stay.
One of the more striking findings in our study was the high prevalence of psychiatric and neurologic disease in our patient population. Close to half of the patients in our study had a significant neurologic and/or psychiatric diagnosis.
This may reflect the anticipated increasing incidence of HIV-related neurologic disease among patients with AIDS, who live longer with ongoing immunosuppression as a result of more effective therapies in the HAART era. 23 It may also reflect the fact that people with serious neurologic impairment from H1V disease may be in particular need of skilled nursing care due to decreased ability to care for themselves. Further, patients with significant psychiatric comorbidity may be less likely as a group to benefit from the impact of the new therapies--and their demanding daily dosing schedules--outside a structured environment with both medical and psychiatric supervision. They may also be more likely to be admitted to a skilled nursing facility earlier in the course of their HIV disease, reflecting a need for more intensive supportive care services than would be available routinely in a noninstitutional setting. Finally, the high prevalence of substance use in our patients--those dually and triply diagnosed, with HIV disease, neuropsychiatric illness, and drug use disorders--converges with the other diagnoses to create a unique range of needs. [24] [25] [26] All of these factors suggest the critical importance of a combination of medical, mental health, drug treatment, and rehabilitative services in long-term care settings in which this vulnerable patient population is likely to become increasingly concentrated. 12~7 Further, it is important to recognize that skilled nursing facilities such as this one in fact may be selecting patients with multiple comorbidities since those able to function at higher levels would tend to be removed progressively from the potential patient pool, leaving only those with no other alternatives to constitute the group eligible and appropriate for long-term care. In addition, in our study, the absence of psychiatric illness was a predictor of survival on multivariate analysis, and neurologic disease and dementia were predictors of long-term stay, suggesting that there may be other selection effects following admission by which patients with neuropsychiatric illness would tend to make up an increasing proportion of the patient population over time.
This trend is substantiated by the increasing serial cross-sectional prevalence of psychiatric illness in the population over time at this facility, from just over 40% in 1995 to close to 60% in 1998 (P < .01) (Figure) . These findings are corroborated by other studies in which psychiatric illness and/or dementia were predictive of increased length of stay or intensity of care among patients with AIDS in hospital or geriatric nursing home settings. 8' 27' 28 This likely will exert pressure on such facilities to keep beds available for more acute, short-term admissions and result in a growing need for other community-based residential alternatives for people with chronic disability from AIDS and these other associated conditions. Moreover, the overall decline in mortality due to more effective antiretroviral therapy will only intensify these changes: Within our population, there was a significant decrease in mortality of those admitted from 1997 to 1998 compared to those from 1995 to 1996 (P < .01). Indeed, at Leeway, all of these trends have resulted in a need for the construction of an additional on-site 10-bed unit, now under way, which will accommodate the growing size of the patient population and be designed especially--both in physical layout and staffing patterns--to care for patients with AIDS and serious mental illness.
As has been described in earlier reports examining the delivery of care to patients with AIDS in geriatric nursing home settings, 9'B our patient population required a high level of medical and nursing intensity and had a higher acuity of illness than would be expected in many other nursing home settings. The high median number of medications (11 in this sample, likely to increase as our therapeutic options advance) and the frequent need for referral to the hospital for acute care interventions, procedures, and outpatient subspecialty consultations all indicate that the care needs for such patients cannot be extrapolated simply from what would be expected in a geriatric nursing home. Although our facility has negotiated a separate daily bed reimbursement rate with our state regulatory agency, intended to reflect the higher acuity level of our population, this may become increasingly problematic over time, especially with capitated payment systems, Medicare, and private insurers, due to the growing complexity and cost of antiretroviral agents and other HIV-specific therapies.
Aside from the clinical and health services aspects of our experience, it is important to note the unique nature and dynamics in the care continuum of a skilled nursing facility for people with AIDS. The relatively small size of the institution, the communitylike nature of the facility--with a common eating area and many group activities--and the long stays compared to an inpatient hospital all contribute to important social and emotional bonds that arise among patients and between patients and staff. For patients and their families, this AIDS-dedi-cated facility may be the first place in which they have been able to speak about and receive support for being affected by AIDS without fear of ostracism or adverse consequences.
For some patients, there is the prospect that they may recover enough to be discharged home; indeed, the remarkable recoveries of some patients at the nursing home--the "Lazarus syndrome" increasingly seen in HIV care--are a testament to the benefits of intensive nursing and rehabilitative care along with HAART. However, for many other patients, it is evident that they either will soon die or will be unlikely ever to leave the facility. This duality both reinforces hopefulness and, whenever a patient dwindles or dies, serves as a reminder of the frailty and uncertainty that still characterize HIV disease even in the HAART era. 29 Thus, the facility serves not only as a refuge from an outside world in which AIDS still carries a heavy stigma, but also as a place of last resort when all other options have failed and AIDS continues to take a heavy toll. These subtle and conflicting themes may pose particular challenges for emotional and psychosocial care for patients, families, and staff at such facilities over time.
These and other special concerns--such as how to address drug use, sexual risk taking, and certain infection control issues in a group environment that seeks to have a noninstitutional ambience--have continued to require close and thoughtful attention as our clinical experience in this facility evolves.
In conclusion, this study suggests that a dedicated skilled nursing facility for people with AIDS can occupy an important and increasingly strategic role in the continuum of care services as AIDS becomes more of a chronic disease. In addition to those admitted for short-term convalescence and the small percentage of patients admitted for respite or terminal care, the largest proportion of patients in such facilities will be those requiring long-term care of indefinite duration.
The success of HAART and other HIV-related therapies carries with it the new challenge of caring for a patient population that survives longer but is not able to respond sufficiently to our new therapeutics--for medical, social, behavioral, or other reasons--to return to autonomous functioning in the community. Skilled nursing facilities such as this one should be integrated into the extending continuum of HIV care services, together with noninstitutional, community-based options for those patients with chronic care needs who may no longer require inpatient nursing care.
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